Paper20164024
The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma.
Starska K and 6 others. Folia Histochem Cytobiol, 2009. Cited by 25 papers, by iCite.
Cite this record
ConductScience Library. The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma. Papers, record 20164024. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20164024
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- The expression of SOCS1 and TLR4-NFkappaB pathway molecules in neoplastic cells as potential biomarker for the aggressive tumor phenotype in laryngeal carcinoma.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Squamous Cell | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Laryngeal Neoplasms | Major topic |
| NF-kappa B | Major topic |
| Suppressor of Cytokine Signaling Proteins | Major topic |
| Toll-Like Receptor 4 | Major topic |
| Aged | |
| Aged, 80 and over | |
| Biomarkers, Tumor | |
| Disease Progression | |
| Female | |
| Humans | |
| Immunohistochemistry | |
| Interleukin-1 Receptor-Associated Kinases | |
| Male | |
| Middle Aged | |
| Phenotype | |
| RNA, Messenger | |
| Reverse Transcriptase Polymerase Chain Reaction | |
| Suppressor of Cytokine Signaling 1 Protein | |
| TNF Receptor-Associated Factor 6 |
Source PubMed
Cited by12
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 25 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42121921 | Interplay Between TLR4 and Gelatinases in Tumour Growth and Metastasis. | Cells | 2026 | https://conductscience.org/library/papers/42121921 | PubMed |
| 40347321 | Inhibition of SIRT1/HSF1 pathway contributes to doxorubicin-induced nephrotoxicity in ovarian tumor-bearing mice. | Apoptosis | 2025 | https://conductscience.org/library/papers/40347321 | PubMed |
| 35116557 | Up-regulation of SOCS4 promotes cell proliferation and migration in esophageal squamous cell carcinoma. | Transl Cancer Res | 2021 | https://conductscience.org/library/papers/35116557 | PubMed |
| 31318878 | Salivary proteomics of canine oral tumors using MALDI-TOF mass spectrometry and LC-tandem mass spectrometry. | PLoS One | 2019 | https://conductscience.org/library/papers/31318878 | PubMed |
| 29051178 | TLR4-Mediated Inflammation Promotes KSHV-Induced Cellular Transformation and Tumorigenesis by Activating the STAT3 Pathway. | Cancer Res | 2017 | https://conductscience.org/library/papers/29051178 | PubMed |
| 27538408 | Ischemic Preconditioning-Induced SOCS-1 Protects Rat Intestinal Ischemia Reperfusion Injury via Degradation of TRAF6. | Dig Dis Sci | 2017 | https://conductscience.org/library/papers/27538408 | PubMed |
| 25973756 | Brucella spp. Lumazine Synthase Induces a TLR4-Mediated Protective Response against B16 Melanoma in Mice. | PLoS One | 2015 | https://conductscience.org/library/papers/25973756 | PubMed |
| 24235843 | Should a Toll-like receptor 4 (TLR-4) agonist or antagonist be designed to treat cancer? TLR-4: its expression and effects in the ten most common cancers. | Onco Targets Ther | 2013 | https://conductscience.org/library/papers/24235843 | PubMed |
| 24127926 | Different cellular localization of NF-κB p65 expression as an indicator of different prognoses of stage I-III gastric cancer patients. | Clin Transl Sci | 2013 | https://conductscience.org/library/papers/24127926 | PubMed |
| 23437123 | Overexpression of miR -155 promotes proliferation and invasion of human laryngeal squamous cell carcinoma via targeting SOCS1 and STAT3. | PLoS One | 2013 | https://conductscience.org/library/papers/23437123 | PubMed |
| 22736025 | TNF receptor-associated factor 6 in advanced non-small cell lung cancer: clinical and prognostic implications. | J Cancer Res Clin Oncol | 2012 | https://conductscience.org/library/papers/22736025 | PubMed |
| 22110526 | Toll-like receptor 4 activation in cancer progression and therapy. | Clin Dev Immunol | 2011 | https://conductscience.org/library/papers/22110526 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IRAK1 | 3654 | PubTator's text mining | https://conductscience.org/library/genes/3654 | NCBI Gene |
| NFKB1 | 4790 | PubTator's text mining | https://conductscience.org/library/genes/4790 | NCBI Gene |
| RELA | 5970 | PubTator's text mining | https://conductscience.org/library/genes/5970 | NCBI Gene |
| SOCS1 | 8651 | PubTator's text mining | https://conductscience.org/library/genes/8651 | NCBI Gene |
| TFG | 10342 | PubTator's text mining | https://conductscience.org/library/genes/10342 | NCBI Gene |
| TLR4 | 7099 | PubTator's text mining | https://conductscience.org/library/genes/7099 | NCBI Gene |
| TRAF6 | 7189 | PubTator's text mining | https://conductscience.org/library/genes/7189 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20164024
GET https://conductscience.org/api/papers/v1/20164024/authors